Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to 91.78%.

  • SOPHiA GENETICS's EBITDA Margin rose 51300.0% to 91.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 83.82%, marking a year-over-year increase of 111900.0%. This contributed to the annual value of 61.65% for FY2024, which is 183300.0% up from last year.
  • SOPHiA GENETICS's EBITDA Margin amounted to 91.78% in Q3 2025, which was up 51300.0% from 100.92% recorded in Q2 2025.
  • Over the past 5 years, SOPHiA GENETICS's EBITDA Margin peaked at 51.04% during Q4 2024, and registered a low of 230.37% during Q1 2022.
  • For the 5-year period, SOPHiA GENETICS's EBITDA Margin averaged around 133.9%, with its median value being 118.87% (2024).
  • Its EBITDA Margin has fluctuated over the past 5 years, first crashed by -738000bps in 2022, then soared by 1014700bps in 2023.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's EBITDA Margin stood at 192.09% in 2021, then soared by 41bps to 112.69% in 2022, then soared by 37bps to 71.25% in 2023, then increased by 28bps to 51.04% in 2024, then crashed by -80bps to 91.78% in 2025.
  • Its last three reported values are 91.78% in Q3 2025, 100.92% for Q2 2025, and 90.2% during Q1 2025.